PECAM1 and prostate neoplasm: Previous studies in orthotopic breast (4T1 and EO771) and prostate tumours have reported a reduction in tumour hypoxia [15,17], increase in tumour perfusion [13–15] and increase in CD31+ vessel density with post-implantation exercise [15].